Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


STEMdiff™ - Products for Differentiating Human Pluripotent Stem Cells

Product Image
Product Description

STEMdiff™ is a line of products from STEMCELL Technologies Inc. specifically optimized for the differentiation of human pluripotent stem cells (hPSCs).  

STEMdiff™ APEL™ Medium (Catalog #05210)
STEMdiff™ APEL™ Medium is a defined, serum-free and animal component-free medium
specifically developed to support hPSC differentiation along ectoderm, mesoderm and endoderm lineages. Developed by STEMCELLTechnologies and based on a published formulation (Ng ES et al. Nat Protoc. 3:768-776, 2008).  STEMdiff™ APEL™ Medium is a versatile, growth factor-free, basal medium that is to be supplemented with specific lineage-inducing factors. Although optimized to be used following maintenance in either
mTeSR™1 or TeSR™2 media and using the EB-based AggreWell™ system, this medium
can also be used to differentiate cells in adherent cell-based systems.  (For more information on AggreWell™ for uniformly-sized EB formation, please visit www.stemcell.com/aggrewell)

Advantages
•    Defined
•    Animal component-free
•    Versatile, growth factor-free formulation to allow for differentiation to multiple lineages

STEMdiff™ Neural Induction Medium (Catalog #05831)
STEMdiff™ Neural Induction Medium is a defined, serum-free medium that is part of a complete system for the differentiation of hPSCs to neural progenitor cells in as little as 12 days. This medium rapidly and efficiently forms neural rosette clusters when used in conjunction with AggreWell™ 800 plates, which ensure uniformly-sized neural aggregate formation.

MDC-Product-Feature_Neural-Rosettes copy.gif
Neural rosette clusters formed using STEMdiff™ Neural Induction Medium can then
be selected and isolated for further experiments using enzyme-free STEMdiff™
Neural Rosette Selection Reagent (Catalog #05832).  Using this novel reagent, neural rosettes virtually “lift off” the plate and do not require any manual isolation. Together this is a complete, convenient and highly efficient system to obtain up to 100% single neural progenitor cells within 12 days.

Advantages
•    Defined
•    Serum-free
•    Rapid and efficient neural induction
                * Neural rosettes within 6 days
                * Single cell NPC populations within 12 days

STEMdiff™ Hematopoietic Differentiation Kit (Catalog #05310) – Coming Soon!
STEMdiff™ Hematopoietic Differentiation Kit is optimized for the differentiation of hPSCs to the hematopoietic lineage and will be available soon.

Advantages
•    Optimized for hPSC differentiation to the hematopoietic lineage
•    Easy-to-use 13-day protocol
•    From hPSCs, generates CD34+ and CD34+CD45+ hematopoietic cells and an average of 150 CFCs per 100,000 cells

For more information about the STEMdiff™ product line, please visit www.stemcell.com/STEMdiff

Product STEMdiff™ - Products for Differentiating Human Pluripotent Stem Cells
Company StemCell Technologies
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

StemCell Technologies
40 Rues des Berges Miniparc Polytec Bâtiment Sirocco, 38000 Grenoble France

Tel: +33.(0)4.76.04.75.30
Fax: +33.(0).4.76.18.99.63
Email: Product.management@stemcell.com



Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!